Founded in 2010, KellBenx, Inc. is a privately held biotechnology company based on Long Island, New York.
KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from maternal blood. Our focus is the development of non-invasive prenatal diagnosis (NIPD) for specific genetic and other inherited disorders.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 04/01/11 | Other | 2.5M | Unknown |